Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Track record
Movers
The Lead Compound
Home
›
Targets
› PNPLA3
PNPLA3
(2 companies · 2 programs)
Companies with an active program directed at PNPLA3.
ProQR Therapeutics N.V.
PRQR
AX-2911
— Metabolic Dysfunction-Associated Steatohepatitis
Preclinical
Wave Life Sciences Ltd.
WVE
WVE-008
— PNPLA3 I148M Liver Disease
Preclinical